Largest companies by net assets
net assets
| Company | Net assets | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 201 | $433.86M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 202 | $429.18M | Healthcare | Medical Devices | United States | Nasdaq |
| 203 | $425.60M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 204 | $422.93M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 205 | $422.60M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 206 | $420.34M | Healthcare | Medical Devices | United States | Nasdaq |
| 207 | $420.00M | Healthcare | Medical Devices | United States | Nasdaq |
| 208 | $409.54M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 209 | $408.21M | Healthcare | Biotechnology | United States | Nasdaq |
| 210 | $407.66M | Healthcare | Biotechnology | United States | Nasdaq |
| 211 | $402.63M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 212 | $398.35M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 213 | $391.99M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 214 | $387.27M | Healthcare | Biotechnology | United States | Nasdaq |
| 215 | $385.48M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 216 | $381.26M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 217 | $374.07M | Healthcare | Biotechnology | United States | Nasdaq |
| 218 | $366.84M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 219 | $365.40M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 220 | $361.87M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 221 | $355.89M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 222 | $353.66M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 223 | $348.30M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 224 | $346.80M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 225 | $346.73M | Healthcare | Biotechnology | United States | Nasdaq |
| 226 | $345.55M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 227 | $343.61M | Healthcare | Medical Devices | United States | Nasdaq |
| 228 | $341.40M | Healthcare | Pharmaceuticals | United States | NYSE |
| 229 | $340.07M | Healthcare | Medical Devices | United States | Nasdaq |
| 230 | $338.09M | Healthcare | Medical Devices | United States | Nasdaq |
| 231 | $334.50M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 232 | $332.35M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 233 | $324.07M | Healthcare | Healthcare Providers | United States | NYSE |
| 234 | $324.05M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 235 | $323.11M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 236 | $321.95M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 237 | $321.51M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 238 | $317.78M | Healthcare | Medical Devices | United States | Nasdaq |
| 239 | $311.91M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 240 | $310.70M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 241 | $305.65M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 242 | $303.90M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 243 | $302.90M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 244 | $287.28M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 245 | $286.89M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 246 | $279.73M | Healthcare | Medical Devices | United States | Nasdaq |
| 247 | $279.32M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 248 | $270.96M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 249 | $265.77M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 250 | $263.84M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 251 | $263.34M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 252 | $262.32M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 253 | $260.27M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 254 | $258.73M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 255 | $256.37M | Healthcare | Medical Devices | United States | Nasdaq |
| 256 | $256.26M | Healthcare | Medical Devices | United States | Nasdaq |
| 257 | $253.86M | Healthcare | Pharmaceuticals | United States | NYSE |
| 258 | $253.78M | Healthcare | Biotechnology | United States | Nasdaq |
| 259 | $252.74M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 260 | $251.39M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 261 | $247.74M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 262 | $247.10M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 263 | $246.22M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 264 | $246.13M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 265 | $244.22M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 266 | $239.66M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 267 | $239.55M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 268 | $239.17M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 269 | $235.60M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 270 | $235.16M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 271 | $235.06M | Healthcare | Biotechnology | United States | Nasdaq |
| 272 | $233.41M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 273 | $232.34M | Healthcare | Biotechnology | United States | Nasdaq |
| 274 | $230.29M | Healthcare | Biotechnology | United States | Nasdaq |
| 275 | $228.31M | Healthcare | Medical Devices | United States | Nasdaq |
| 276 | $220.58M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 277 | $220.19M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 278 | $219.51M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 279 | $219.26M | Healthcare | Biotechnology | United States | Nasdaq |
| 280 | $219.25M | Healthcare | Pharmaceuticals | United States | NYSE |
| 281 | $218.61M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 282 | $217.65M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 283 | $217.13M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 284 | $216.87M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 285 | $216.00M | Healthcare | Medical Devices | United States | Nasdaq |
| 286 | $214.78M | Healthcare | Biotechnology | United States | Nasdaq |
| 287 | $214.58M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 288 | $211.14M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 289 | $210.59M | Healthcare | Biotechnology | United States | Nasdaq |
| 290 | $209.89M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 291 | $204.62M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 292 | $204.16M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 293 | $201.86M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 294 | $195.11M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 295 | $192.29M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 296 | $190.74M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 297 | $186.06M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 298 | $185.98M | Healthcare | Medical Devices | United States | Nasdaq |
| 299 | $182.35M | Healthcare | Medical Devices | United States | Nasdaq |
| 300 | $181.08M | Healthcare | Biotechnology | United States | Nasdaq |
U.S.-exchange common stocks; ADRs and funds excluded. 724 companies. Reported USD values. TTM means trailing twelve months; companies without a comparable value are excluded.